SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market
Holding SABS?
Track your performance easily

SAB Biotherapeutics (SABS) Cash flow

73 Followers

SAB Biotherapeutics Cash Flow

SABS's free cash flow for Q2 2024 was $-7.77M. For the 2024 fiscal year, SABS's free cash flow was decreased by $277.43K and operating cash flow was $-7.72M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -28.53M$ -25.12M$ -23.46M$ 3.76M$ 10.00M$ -9.21M
Investing Cash Flow
$ -20.20M$ -152.70K$ -2.09M$ -10.94M$ -12.72M$ -608.75K
Financing Cash Flow
$ -1.22M$ 66.77M$ 1.05M$ 34.12M$ 8.98M$ 3.68M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 16.43M$ 98.76M$ 15.05M$ 39.55M$ 12.61M$ 6.35M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 250.01K$ 245.48K-$ 294.46K$ 469.15K$ 428.48K
Issuance Of Capital Stock
--$ 7.68M-$ 9.90M$ 4.30M
Issuance Of Debt
$ -1.01M$ 638.21K$ -3.66M$ -203.12K$ 661.61K$ 0.00
Repayment Of Debt
$ -1.01M$ -126.98K$ -2.42M$ -203.12K$ -1.58M$ -623.27K
Free Cash Flow
$ -28.78M$ -25.27M$ -25.55M$ -7.19M$ -2.73M$ -9.82M
Domestic Sales
------
Foreign Sales
------
Currency in USD

SAB Biotherapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis